Subsequent attendance in a breast cancer screening program after a false-positive result in the Local Health Authority of Bologna (Italy). 2021

Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
Department of Public Health, LHA Bologna, Via Boldrini, 12, 40121, Bologna, Italy. lorena.squillace@ausl.bologna.it.

We conducted a cross-sectional study to assess the likelihood of returning for routine breast cancer screening among women who have experienced a false-positive result (FPR) and to describe the possible individual and organizational factors that could influence subsequent attendance to the screening program. Several information were collected on demographic and clinical characteristics data. Electronic data from 2014 to 2016 related to breast screening program of the Local Health Authority (LHA) of Bologna (Italy) of women between 45 and 74 years old were reviewed. A total of 4847 women experienced an FPR during mammographic screening and were recalled to subsequent round; 80.2% adhered to the screening. Mean age was 54.2 ± 8.4 years old. Women resulted to be less likely to adhere to screening if they were not-Italian (p = 0.001), if they lived in the Bologna district (p < 0.001), if they had to wait more than 5 days from II level test to end of diagnostic procedures (p = 0.001), if the diagnostic tests were performed in a hospital with the less volume of activity and higher recall rate (RR) (p < 0.001) and if they had no previous participation to screening tests (p < 0.001). Our results are consistent with previous studies, and encourages the implementation and innovation of the organizational characteristics for breast cancer screening. The success of screening programs requires an efficient indicators monitoring strategy to develop and evaluate continuous improvement processes.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008327 Mammography Radiographic examination of the breast. 3D-Mammography,Digital Breast Tomosynthesis,Digital Mammography,X-ray Breast Tomosynthesis,3D Mammography,3D-Mammographies,Breast Tomosyntheses, Digital,Breast Tomosyntheses, X-ray,Breast Tomosynthesis, Digital,Breast Tomosynthesis, X-ray,Digital Breast Tomosyntheses,Digital Mammographies,Mammographies,Mammographies, Digital,Mammography, Digital,X ray Breast Tomosynthesis,X-ray Breast Tomosyntheses
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010358 Patient Participation Patient involvement in the decision-making process in matters pertaining to health. Patient Activation,Patient Empowerment,Patient Engagement,Patient Involvement,Patient Participation Rates,Activation, Patient,Empowerment, Patient,Engagement, Patient,Involvement, Patient,Participation Rate, Patient,Participation Rates, Patient,Participation, Patient,Patient Participation Rate
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076862 Diagnostic Screening Programs Services for the presumptive identification of unrecognized disease in an apparently healthy, asymptomatic population by means of tests, examinations or other procedures that can be applied rapidly and easily to the target population. (from World Health Organization http://www.who.int/cancer/prevention/diagnosis-screening/screening/en/ Oct. 24,2017) Screening Programs, Diagnostic,Diagnostic Screening Program,Program, Diagnostic Screening,Programs, Diagnostic Screening,Screening Program, Diagnostic

Related Publications

Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
May 2011, Breast cancer research and treatment,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
February 2013, Cancer epidemiology,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
January 2003, Journal of medical screening,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
June 2013, Journal of medical screening,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
January 2024, JAMA oncology,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
January 2002, Breast cancer research : BCR,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
September 2020, Acta bio-medica : Atenei Parmensis,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
October 2004, Cancer,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
May 2003, Cancer causes & control : CCC,
Lorena Squillace, and Lorenzo Pizzi, and Flavia Rallo, and Carmen Bazzani, and Gianni Saguatti, and Francesca Mezzetti
January 1999, Canadian family physician Medecin de famille canadien,
Copied contents to your clipboard!